LIPOSYN II 20% 10 %
SAFFLOWER OIL : 10 % SOYBEAN OIL : 10 % EGG PHOSPHOLIPIDS : 1.2 % · DIN 00720968 · HOSPIRA HEALTHCARE ULC
Health Canada status: CANCELLED POST MARKET
What is LIPOSYN II 20%?
LIPOSYN II 20% 10 % contains SAFFLOWER OIL : 10 % SOYBEAN OIL : 10 % EGG PHOSPHOLIPIDS : 1.2 %. It is listed in the Health Canada Drug Product Database under DIN 00720968, held by HOSPIRA HEALTHCARE ULC, supplied as EMULSION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00720968 |
|---|---|
| Brand name | LIPOSYN II 20% |
| Generic / active ingredient | SAFFLOWER OIL : 10 % SOYBEAN OIL : 10 % EGG PHOSPHOLIPIDS : 1.2 % |
| Manufacturer | HOSPIRA HEALTHCARE ULC |
| Strength | 10 % |
| Dosage form | EMULSION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05BA02 FAT EMULSIONS |
| AHFS class | 40:20.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2014 |
| Original market date | 1987-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05BA02 FAT EMULSIONS. 3 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLINOLEIC 20% | 16 % | EMULSION | BAXTER CORPORATION | MARKETED | DIN 02344327 |
| INTRALIPID 20% | 20 % | EMULSION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02065673 |
| SMOFLIPID 20% | 6 % | EMULSION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02396963 |
| 10% TRAVAMULSION LIQ IV | 1.2 G / 100 ML | LIQUID | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | CANCELLED POST MARKET | DIN 02016028 |
| 20% TRAVAMULSION LIQ IV | 20 G / 100 ML | LIQUID | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | CANCELLED POST MARKET | DIN 02016036 |
| COLIP 20% | 15 G / 100 ML | EMULSION | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | CANCELLED POST MARKET | DIN 02230772 |
| INTRALIPID 10% | 10 % | EMULSION | FRESENIUS KABI CANADA LTD | DORMANT | DIN 02065681 |
| INTRALIPID 30% | 30 % | EMULSION | FRESENIUS KABI CANADA LTD | DORMANT | DIN 02216175 |
| LIPOSYN II 10% | 5 % | EMULSION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00720976 |
| LIPOSYN II INJ 10% | 700 MG / 100 ML | EMULSION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00818712 |
Who else supplies FAT EMULSIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FAT EMULSIONS appears in 16 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.